Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $1.10T · View financials
Decision snapshot: AVTX stock price vs AVGO: inconclusive — current versus $0.04 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at AVGO's multiple
Implied fair value · at AVTX's multiple
Needs AVTX P/S.
Live quote
As of 2024-12-31
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: AVTX FY 2025 (ended Dec 31, 2025) · AVGO FY 2025 (ended Nov 2, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 94% equity / 6% debt · EV / Revenue 18.03x · EV / EBITDA 30.32x
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
AVALO THERAPEUTICS, INC. · implied price per share
Bear
$1.24
Base
$1.45
Bull
$1.67
Broadcom Inc. · implied price per share
Bear
$51.89
Base
$61.05
Bull
$70.21
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.24x
0.80x
Net debt / EBITDA
Leverage against operating earnings
1.03x
1.29x
Cash and equivalents
Liquid reserves on the balance sheet
$98.34M
$16.18B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
CytomX Therapeutics, Inc.
AVTX vs CTMX
IDEAYA Biosciences, Inc.
AVTX vs IDYA
Ocugen, Inc.
AVTX vs OCGN
CLOVER HEALTH INVESTMENTS, CORP. /DE
AVTX vs CLOV
Citius Pharmaceuticals, Inc.
AVTX vs CTXR
NVIDIA Corporation
AVTX vs NVDA
Intel Corporation
AVTX vs INTC
Advanced Micro Devices, Inc.
AVTX vs AMD
QUALCOMM Incorporated
AVTX vs QCOM
Cisco Systems, Inc.
AVTX vs CSCO
$20.26M
$65.14B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
Edwyn research
